AdipoGen Life Sciences

CTRP5 (human) (rec.) (His)

CHF 230.00
In stock
AG-40A-0142-C01010 µgCHF 230.00
AG-40A-0142-C05050 µgCHF 575.00
More Information
Product Details
Synonyms Complement C1q Tumor Necrosis Factor-related Protein 5; C1QTNF5
Product Type Protein
Properties
Source/Host E. coli
Sequence Human CTRP5 (aa 16-243) is fused at the N-terminus to a His-tag.
Crossreactivity Human
MW ~26kDa (SDS-PAGE)
Purity ≥90% (SDS-PAGE)
Endotoxin Content <1EU/μg purified protein (LAL test; Lonza).
Reconstitution Reconstitute in distilled water.
Formulation Lyophilized from a 0.2μm-filtered solution in 55mM TRIS-Cl, pH 8.2, containing 150mM NaCl.
Other Product Data UniProt link Q9BXJ0: Complement C1q tumor necrosis factor-related protein 5 (human)
Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice After reconstitution, prepare aliquots and store at -20°C.
Avoid freeze/thaw cycles.
Centrifuge lyophilized vial before opening and reconstitution.
Use/Stability Stable for at least 6 months after receipt when stored at -20°C.
Working aliquots are stable for up to 3 months when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description

CTRP5 (C1qTNF-related protein 5; C1QTNF5) belongs to a highly conserved family of adiponectin paralogs. CTRP5 mediates activation of AMP-activated protein kinase (AMPK) in muscle and liver cells, thereby regulating glucose and lipid metabolism. Serum levels of CTRP5 are significantly higher in obese/diabetic animal models compared to normal controls. Furthermore, CTRP5 may be a putative biomarker for mitochondrial dysfunction. Defects in C1QTNF5 are a cause of late-onset retinal degeneration (LORD).

Product References
  1. Regulation and Function of C1Q/TNF-related Protein-5 (CTRP-5) in the Context of Adipocyte Biology: A.Schmid, et al.; Exper. Clin. Endocrinol. Diab. 121, 310 (2013)
  2. CTRP5 promotes transcytosis and oxidative modification of low-density lipoprotein and the development of atherosclerosis: C. Li, et al.; Atherosclerosis 278, 197 (2018)
  3. AMPK modulation ameliorates dominant disease phenotypes of CTRP5 variant in retinal degeneration: K.J. Miyagishima, et al.; Nature Comm. Biol. 4, 1360 (2021)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.